StockData
Kazia Therapeutics Ltd logo

Kazia Therapeutics Ltd (KZIA) stock

KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 17, 2026Score 1/30
$4.92−0.45 (-8.38%)

Close on Nov 20, 2026Market cap $7.96MP/E –Yield –

Kazia Therapeutics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

No operating income figures for Kazia Therapeutics

Kazia Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Kazia Therapeutics figures

See a number that looks wrong?